Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma April 8, 2021
Enrollment begins in phase III study of futibatinib in CCA harboring FGFR2 gene rearrangements April 8, 2021
FDA clears IND for phase II study of MIT-001 as therapy of CCRT-induced oral mucositis in HNSCC April 8, 2021
Bridge Biotherapeutics begins phase I/II trial of BBT-176 in EGFR-mutant NSCLC with C797S April 7, 2021
RSS